Literature DB >> 29381452

Recommandations de l'Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.

Ricardo A Rendon1, Ross J Mason2, Karim Marzouk3, Antonio Finelli4, Fred Saad5, Alan So6, Phillipe Violette7,8, Rodney H Breau9.   

Abstract

Entities:  

Year:  2017        PMID： 29381452      PMCID： PMC5659858          DOI： 10.5489/cuaj.4888

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  102 in total

1.  Transrectal prostate ultrasonography: variability of interpretation.

Authors:  M I Resnick; J A Smith; P T Scardino; M J Egger; A Hernandez; S C Rose
Journal:  J Urol       Date:  1997-09       Impact factor: 7.450

Review 2.  Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancer.

Authors:  Linda A Bradley; Glenn E Palomaki; Steven Gutman; David Samson; Naomi Aronson
Journal:  J Urol       Date:  2013-03-29       Impact factor: 7.450

3.  PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study.

Authors:  Marc C Gittelman; Bernard Hertzman; James Bailen; Thomas Williams; Isaac Koziol; Ralph Jonathan Henderson; Mitchell Efros; Mohamed Bidair; John F Ward
Journal:  J Urol       Date:  2013-02-14       Impact factor: 7.450

4.  PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial.

Authors:  Sheila M J Aubin; Jennifer Reid; Mark J Sarno; Amy Blase; Jacqueline Aussie; Harry Rittenhouse; Roger Rittmaster; Gerald L Andriole; Jack Groskopf
Journal:  J Urol       Date:  2010-09-17       Impact factor: 7.450

5.  Extent of prostate-specific antigen contamination in the Spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Authors:  Marcos Luján; Alvaro Páez; Carlos Pascual; Javier Angulo; Elena Miravalles; Antonio Berenguer
Journal:  Eur Urol       Date:  2006-05-03       Impact factor: 20.096

6.  Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above.

Authors:  Andrew Vickers; Emily A Vertosick; Daniel D Sjoberg; Monique J Roobol; Freddie Hamdy; David Neal; Anders Bjartell; Jonas Hugosson; Jenny L Donovan; Arnauld Villers; Stephen Zappala; Hans Lilja
Journal:  J Urol       Date:  2016-09-28       Impact factor: 7.450

7.  Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for staging.

Authors:  Herbert Augustin; Markus Graefen; Jüri Palisaar; Jakob Blonski; Andreas Erbersdobler; Fedor Daghofer; Hartwig Huland; Peter G Hammerer
Journal:  J Clin Oncol       Date:  2003-08-01       Impact factor: 44.544

8.  Quantifying the role of PSA screening in the US prostate cancer mortality decline.

Authors:  Ruth Etzioni; Alex Tsodikov; Angela Mariotto; Aniko Szabo; Seth Falcon; Jake Wegelin; Dante DiTommaso; Kent Karnofski; Roman Gulati; David F Penson; Eric Feuer
Journal:  Cancer Causes Control       Date:  2007-11-20       Impact factor: 2.506

9.  Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men.

Authors:  Claire de la Calle; Dattatraya Patil; John T Wei; Douglas S Scherr; Lori Sokoll; Daniel W Chan; Javed Siddiqui; Juan Miguel Mosquera; Mark A Rubin; Martin G Sanda
Journal:  J Urol       Date:  2015-01-28       Impact factor: 7.450

10.  A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden.

Authors:  Andrew J Vickers; Angel M Cronin; Gunnar Aus; Carl-Gustav Pihl; Charlotte Becker; Kim Pettersson; Peter T Scardino; Jonas Hugosson; Hans Lilja
Journal:  BMC Med       Date:  2008-07-08       Impact factor: 8.775
View more
  21 in total

1.  Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update.

Authors:  J Curtis Nickel; Lorne Aaron; Jack Barkin; Dean Elterman; Mahmoud Nachabé; Kevin C Zorn
Journal:  Can Urol Assoc J       Date:  2018-10       Impact factor: 1.862

2.  Prostate-specific antigen (PSA) screening rates and factors associated with screening in Eastern Canadian men: Findings from cross-sectional survey data.

Authors:  Devan Tchir; Marwa Farag; Michael Szafron
Journal:  Can Urol Assoc J       Date:  2020-07       Impact factor: 1.862

Review 3.  A review of prostate cancer imaging, positron emission tomography, and radiopharmaceutical-based therapy.

Authors:  Amy Pawson; Zonia Ghumman; Phillip H Kuo; Hossein Jadvar; Twyla Bartel; Bobby Shayegan; Katherine Zukotynski
Journal:  Can Urol Assoc J       Date:  2020-04-01       Impact factor: 1.862

4.  PSA screening: Time to overcome our brand confusion.

Authors:  D Robert Siemens; Martin Gleave
Journal:  Can Urol Assoc J       Date:  2017-10       Impact factor: 1.862

5.  Quick and painless: 2018 Updates on guideline recommendations.

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2019-11       Impact factor: 3.275

Review 6.  Shared decision-making in urology and female pelvic floor medicine and reconstructive surgery.

Authors:  David A Ossin; Emily C Carter; Rufus Cartwright; Philippe D Violette; Shilpa Iyer; Geraldine T Klein; Sangeeta Senapati; Zachary Klaassen; Sylvia M Botros
Journal:  Nat Rev Urol       Date:  2021-12-20       Impact factor: 14.432

7.  Prostate cancer screening among family physicians in Ontario: An update on attitudes and current practice.

Authors:  Jason Paul Akerman; Christopher B Allard; Camilla Tajzler; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

8.  Incidentalomas of the prostate detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.

Authors:  Miles P Mannas; Taeweon Lee; Maral Pourghiasian; Don C Wilson; Peter C Black
Journal:  Can Urol Assoc J       Date:  2019-11-29       Impact factor: 1.862

9.  Prostate-specific antigen testing for prostate cancer screening: A national survey of Canadian primary care physicians' opinions and practices.

Authors:  Mitchell Geoffrey Goldenberg; Sean C Skeldon; Madhur Nayan; Yegappan Suppiah; Linda Chow; Elise Fryml; David Greenberg; Rajiv K Singal; S Larry Goldenberg
Journal:  Can Urol Assoc J       Date:  2017-11-01       Impact factor: 1.862

10.  The evolving role of germline genetic testing and management in prostate cancer: Report from the Princess Margaret Cancer Centre international retreat.

Authors:  Roderick Clark; Miran Kenk; Kristen McAlpine; Emily Thain; Kirsten M Farncombe; Colin C Pritchard; Robert Nussbaum; Alexander W Wyatt; Johann de Bono; Danny Vesprini; Yvonne Bombard; Justin Lorentz; Steven Narod; Raymond Kim; Neil Fleshner
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.